European association for clinical pharmacology and therapeutics young clinical pharmacologists working group: a cornerstone for the brighter future of clinical pharmacology.
Clinical pharmacology
Education
Medical specialty
Mobility
Research
Social networking
Journal
European journal of clinical pharmacology
ISSN: 1432-1041
Titre abrégé: Eur J Clin Pharmacol
Pays: Germany
ID NLM: 1256165
Informations de publication
Date de publication:
Apr 2022
Apr 2022
Historique:
received:
07
12
2021
accepted:
10
01
2022
pubmed:
18
1
2022
medline:
19
3
2022
entrez:
17
1
2022
Statut:
ppublish
Résumé
The European Association for Clinical Pharmacology and Therapeutics (EACPT) is a leading society in Europe serving the European and global Clinical Pharmacology and Therapeutics community. Its specific aims include promotion of the utilisation and divulgation of the utility of clinical pharmacology services in health care delivery. EACPT currently has four active working groups (WGs): Education, Regulatory affairs, Clinical research and Young Clinical Pharmacologists (YCP WG). EACPT YCP WG was established in 2015 with the idea of improving education, research, training and networking/mobility opportunities for YCPs across Europe and globe. The main objective of the present manuscript is to provide detailed information on general characteristics, structure, chronogram, objectives, accomplishments and current/future focus areas of the EACPT YCP WG. Consequently, we tend to notably enhance EACPT YCP WG's visibility, increase the number of its members and mobility/networking options and to expand areas of activity even more. Moreover, by this we can also make clinical pharmacology more attractive to early career fellows and colleagues and empower its position alongside other medical specialties.
Identifiants
pubmed: 35037981
doi: 10.1007/s00228-022-03277-3
pii: 10.1007/s00228-022-03277-3
pmc: PMC8761867
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
691-694Informations de copyright
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Références
Br J Clin Pharmacol. 2016 Feb;81(2):223-7
pubmed: 26466826
Br J Clin Pharmacol. 2006 Dec;62(6):717-8
pubmed: 17118128
Lancet. 2006 Mar 11;367(9513):799-800
pubmed: 16530562
Clin Drug Investig. 2021 Aug;41(8):701-710
pubmed: 34232478
Eur J Clin Pharmacol. 2019 Jun;75(6):743-750
pubmed: 31093706